[免疫抑制剂塔克罗利斯的生物合成:一篇评论]
Liqun Jin1, Di Lu1, Minglin Xing1
1College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou 310014, Zhejiang, China.
Sheng wu gong cheng xue bao = Chinese journal of biotechnology
|August 25, 2023
概括
本综述探讨了通过优化其生物合成途径和发酵过程来增强塔克罗利斯 (FK506) 的生产. 目标是克服目前生产这种重要免疫抑制药物的瓶.
科学领域:
- 生物技术是生物技术.
- 制药科学 制药科学
- 免疫学 免疫学 免疫学
背景情况:
- 塔克罗利 (FK506) 是一种重要的宏类免疫抑制剂,用于预防器官移植排斥.
- 目前的生产方法面临着重大瓶,限制了可用性.
- 生物合成和发酵的进步对于改善塔克罗利斯产量至关重要.
结论:
- 成功实施代谢和发酵工程可以显著提高塔克罗利斯的生产.
- 解决生物合成瓶对于满足对塔克罗利斯的临床需求至关重要.
- 本综述为未来对塔克罗利斯生物合成和工业生产的研究提供了路线图.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
195
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
195
Cell-mediated Immune Responses
68.9K
Overview
68.9K


